ConductScience.org, home

Paper21531979

Autoimmunity associated with immunotherapy of cancer.

Amos SM and 6 others. Blood, 2011. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Autoimmunity associated with immunotherapy of cancer. Papers, record 21531979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21531979

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autoimmunity associated with immunotherapy of cancer.
PubMed
Journal
Blood
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
3.19
iCite
Revised in PubMed
2021-02-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amos SMSally M
2Duong CPConnie P M
3Westwood JAJennifer A
4Ritchie DSDavid S
5Junghans RPRichard P
6Darcy PKPhillip K
7Kershaw MHMichael H

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoimmunityMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Humans

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
41383611TRIM21 regulation of IRF-mediated type I interferon signaling in systemic autoimmune diseases.Front Immunol2025https://conductscience.org/library/papers/41383611PubMed
41041059Dissecting Tertiary Lymphoid Structures in Cancer: Maturation, Localization and Density.Theranostics2025https://conductscience.org/library/papers/41041059PubMed
40734391Severe oral and cutaneous immune-related adverse events induced by PD-1 inhibitors and antibody-drug conjugates: Case reports and management strategies.Sci Prog2025https://conductscience.org/library/papers/40734391PubMed
40141809Anti-Cancer Strategies Using Anaerobic Spore-Forming Bacteria Clostridium: Advances and Synergistic Approaches.Life (Basel)2025https://conductscience.org/library/papers/40141809PubMed
40093652Immune-based strategies for the treatment of biofilm infections.Biofilm2025https://conductscience.org/library/papers/40093652PubMed
38414708Dupilumab-Related Diabetes Mellitus With Reversal of Symptoms in a Non-genetically Predisposed Patient.Cureus2024https://conductscience.org/library/papers/38414708PubMed
38260723Transplantable Murine Tumors in the Studies of Peptide Antitumor Vaccines.Oncol Rev2023https://conductscience.org/library/papers/38260723PubMed
37962824Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities.Curr Treat Options Oncol2023https://conductscience.org/library/papers/37962824PubMed
37584709PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37584709PubMed
37511873Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer.Life (Basel)2023https://conductscience.org/library/papers/37511873PubMed
37345057Recent Advances in Molecular Mechanisms of Cancer Immunotherapy.Cancers (Basel)2023https://conductscience.org/library/papers/37345057PubMed
36678712Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease.Pharmaceutics2022https://conductscience.org/library/papers/36678712PubMed
35920952Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.Curr Rheumatol Rep2022https://conductscience.org/library/papers/35920952PubMed
35761353Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1.BMC Chem2022https://conductscience.org/library/papers/35761353PubMed
35686131Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens.Front Immunol2022https://conductscience.org/library/papers/35686131PubMed
35459932Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse.Heredity (Edinb)2022https://conductscience.org/library/papers/35459932PubMed
35335994LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection.Pharmaceutics2022https://conductscience.org/library/papers/35335994PubMed
34734110Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.Adv Ther (Weinh)2021https://conductscience.org/library/papers/34734110PubMed
34642183Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.Cancer Res2021https://conductscience.org/library/papers/34642183PubMed
34532602Current status and future perspectives of onco-cardiology: Importance of early detection and intervention for cardiotoxicity, and cardiovascular complication of novel cancer treatment.Glob Health Med2021https://conductscience.org/library/papers/34532602PubMed

See all 82 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21531979

GET https://conductscience.org/api/papers/v1/21531979/cited_by?page=2